Skip to main content

About Study Course

Credit points / ECTS:3 / 4.5
Course supervisor:Larisa Umnova
Study type:Full time
Course level:Master's
Target audience:Clinical Pharmacy
Language:Latvian
Branch of science:Basic Sciences of Medicine, including Pharmacy; Clinical Pharmacy

Objective

To provide students with knowledge in clinical areas – pathophysiology of cardiovascular diseases, clinical manifestations, evaluation of examinations, basic methods of treatment and pharmacotherapy options for cardiovascular diseases.
The study module comprises an integrated training cycle in which the student is gradually introduced to the pathological physiology of a group of diseases, clinical pharmacology, clinical manifestations, examination possibilities, interpretation of examination data, principles of treatment and pharmacotherapy possibilities.

Prerequisites

Human anatomy, physiology and pathology, medical biochemistry, pharmacology.

Learning outcomes

Knowledge

As a result of successfully completing the course, the student will have knowledge of the following:
• mechanisms of origin of cardiovascular diseases;
• the most common clinical manifestations and complications of cardiovascular diseases;
• cardiovascular disease examination options;
• basic types of treatment of cardiovascular diseases;
• pharmacotherapy options for cardiovascular diseases.

Skills

The student will be able:
• to interpret cardiovascular system examination results;
• to assess pharmacotherapy for cardiovascular diseases.

Competence

The student will be able:
• in collaboration with the medical practitioners, to determine a pharmacotherapy plan for an individual patient with a cardiovascular disease;
• to assess the advantages and disadvantages of pharmacotherapy methods in relation to the patient’s examination data;
• to monitor the progress of pharmacotherapy, predict side effects and plan the prevention thereof, and provide the necessary information to other medical specialists.

Study course planning

Course planning not avalible right now.